Problem statement: Answer the multiple-choice question.
Question: Which drug has a -16.503% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCN(CC(=O)Nc1c(F)cccc1F)C(=O)/C=C/c1ccc2c(c1)OCO2
(b) CC(=O)Nc1ccc(S(=O)(=O)NCCC(=O)OCc2nnc(-c3ccccc3)o2)cc1
Answer: b. CC(=O)Nc1ccc(S(=O)(=O)NCCC(=O)OCc2nnc(-c3ccccc3)o2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)Nc1ccc(S(=O)(=O)NCCC(=O)OCc2nnc(-c3ccccc3)o2)cc1
CC(=O)Nc1ccc(S(=O)(=O)NCCC(=O)OCc2nnc(-c3ccccc3)o2)cc1
(5-phenyl-1,3,4-oxadiazol-2-yl)methyl 3-[(4-acetamidophenyl)sulfonylamino]propanoate